Recursion Pharmaceuticals Inc Clas (RXRX)
CapEx to Revenue
25.54%
Quarterly · Period ending:
RXRX CapEx to Revenue
Latest reported25.54%period ending
Latest reported25.54%period ending
RXRX Quarterly CapEx/Revenue (0.00% → 25.54%)
Latest values, visible window
High-resolution chart · PNG
RXRX capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 25.5411% | |
| 5.2225% | |
| 3.5005% | |
| 4.6957% | |
| 16.4896% | |
| 12.4246% | |
| 36.5329% | |
| 17.491% | |
| 29.0336% | |
| 49.3144% | |
| 22.7504% | |
| 8.1865% | |
| 36.0203% | |
| 44.0086% | |
| 58.3431% | |
| 65.6018% | |
| 215.2751% | |
| 81.94% | |
| 178.56% | |
| 388.24% | |
| 248.48% | |
| 776.64% | |
| 179.9686% | |
| 95.8237% | |
| 0% | |
| 0% |